(19)

(11)

EP 1 163 345 A1

(12)

(43) Date of publication: 19.12.2001 Bulletin 2001/51 (21) Application number: 00919658.5 (22) Date of filing: 23.03.2000

(51) International Patent Classification (IPC)7: C12N 15/31, C07K 14/37, C12Q 1/04 (86) International application number: PCT/US0007/995 (87) International publication number: WO 0056/894 (28.09.2000 Gazette 2000/39)

(84) Designated Contracting States: AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE Designated Extension States: AL LT LV MK RO SI (30) Priority: 23.03.1999 US 125717 P (71) Applicant: Cytoclonal Pharmaceutics Inc. Dallas, Texas 75235 (US)	(72) Inventors: SIDHU, Rajinder, S. Dallas, TX 75252 (US) BOLLON, Arthur, P. Dallas, TX 75234 (US) MU, Jing-Hong Richardson, TX 75080 (US) (74) Representative: UEXKÜLL & STOLBERG  Patentanwälte Beselerstrasse 4 22607 Hamburg 22607 Hamburg (DE)